What is the treatment for Ramsay Hunt syndrome (Ramsay Hunt syndrome type 2, herpes zoster oticus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ramsey Hunt syndrome treatment should involve prompt systemic antiviral therapy and systemic steroids, as outlined in the clinical practice guideline for acute otitis externa 1. The treatment approach typically includes a combination of antiviral medications, such as acyclovir or valacyclovir, and corticosteroids, like prednisone, to reduce inflammation and manage symptoms.

  • Key considerations for treatment include:
    • Starting antiviral therapy as early as possible after symptom onset
    • Using corticosteroids to reduce inflammation and prevent complications
    • Managing pain with analgesics, such as acetaminophen or NSAIDs, and considering gabapentin or pregabalin for neuropathic pain
    • Protecting the eye with artificial tears and lubricating ointment to prevent corneal damage if facial paralysis is present
    • Recommending physical therapy to maintain muscle tone and prevent contractures The goal of treatment is to target the underlying viral infection, reduce inflammation, manage pain, and prevent complications while the nerve heals, which can take several weeks to months, as noted in the clinical practice guideline 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Treatment Options for Ramsey Hunt Syndrome

  • The treatment for Ramsey Hunt syndrome typically involves antiviral medications, such as acyclovir or famciclovir, in combination with corticosteroids like prednisone 2, 3, 4, 5, 6.
  • Studies have shown that early treatment with acyclovir and prednisone can improve the outcome of recovery from facial palsy 3.
  • The use of famciclovir has been found to have a higher complete recovery rate compared to acyclovir, especially in patients without hypertension and diabetes mellitus 5.
  • Combination therapy with antiviral medication and corticosteroids is preferable for patients with Ramsey Hunt syndrome, as it improves the restoration of facial nerve function 6.

Administration and Dosage

  • Acyclovir can be administered intravenously or orally, with no significant difference in facial nerve outcome between the two routes of administration 3, 4.
  • The recommended dosage for acyclovir is 800 mg, five times daily, and for famciclovir is 500 mg, three times daily 2, 5.
  • The treatment duration is typically 7-10 days for both acyclovir and famciclovir 2, 4, 5.

Efficacy and Outcomes

  • Studies have reported overall recovery rates ranging from 75% to 82.6% with acyclovir treatment 3, 4.
  • The use of famciclovir has been found to have a higher complete recovery rate, with a significant difference in complications and disease severity compared to acyclovir 5.
  • Early treatment with antiviral medication and corticosteroids can reduce nerve degeneration and improve hearing recovery 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ramsay Hunt syndrome.

Journal of neurology, neurosurgery, and psychiatry, 2001

Research

Acyclovir in the treatment of Ramsay Hunt syndrome.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2003

Research

Comparison of Acyclovir and Famciclovir for Ramsay Hunt Syndrome.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2017

Research

Combination therapy is preferable for patients with Ramsay Hunt syndrome.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.